Oncternal Therapeutics Inc.

15/07/2024 | Press release | Distributed by Public on 15/07/2024 13:09

Oncternal Announces Enrollment Completed and Dosing Initiated for Sixth Dose Cohort of Phase 1/2 Study of ONCT 534 for the Treatment of R/R Metastatic Castration Resistant[...]

Read this content
Click here to read the original version at the source's official website. The text of this article is not available at the moment.